Cargando…
Reduced Costs for Staphylococcus aureus Carriers Treated Prophylactically with Mupirocin and Chlorhexidine in Cardiothoracic and Orthopaedic Surgery
BACKGROUND: A multi centre double-blind randomised-controlled trial (M-RCT), carried out in the Netherlands in 2005–2007, showed that hospitalised patients with S. aureus nasal carriage who were treated prophylactically with mupirocin nasal ointment and chlorhexidine gluconate medicated soap (MUP-CH...
Autores principales: | van Rijen, Miranda M. L., Bode, Lonneke G. M., Baak, Diane A., Kluytmans, Jan A. J. W., Vos, Margreet C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419251/ https://www.ncbi.nlm.nih.gov/pubmed/22916209 http://dx.doi.org/10.1371/journal.pone.0043065 |
Ejemplares similares
-
Nasal microbiome disruption and recovery after mupirocin treatment in Staphylococcus aureus carriers and noncarriers
por: Baede, Valérie O., et al.
Publicado: (2022) -
Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
por: Wertheim, Heiman FL, et al.
Publicado: (2005) -
591. Mupirocin and Chlorhexidine Resistance in Staphylococcus aureus Isolated from Children in South Korea
por: Na Kim, Bi, et al.
Publicado: (2019) -
Susceptibility to chlorhexidine and mupirocin among
methicillin-resistant Staphylococcus aureus clinical isolates
from a teaching hospital
por: Bes, Taniela Marli, et al.
Publicado: (2021) -
Estimated Methicillin-Resistant Staphylococcus aureus Decolonization in Intensive Care Units Associated With Single-Application Chlorhexidine Gluconate or Mupirocin
por: Lofgren, Eric T., et al.
Publicado: (2021)